MedPath

Development of histopathological methodology without staining using a spectroscopy

Not Applicable
Suspended
Conditions
Esophageal, gastric, colorectal, hepatic, pancreatic, bile duct, and gallbladder cancer
Registration Number
JPRN-UMIN000017045
Lead Sponsor
Advanced Cancer Translational Research Institute, Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

(1) synchronous or metachronous malignancy. (2) pregnant or breastfeeding women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Accuracy of diagnosis of cancer cells by spectroscopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath